Literature DB >> 8280957

Serial change of gastric mucosa after challenging with Helicobacter pylori in the cynomolgus monkey.

S Takahashi1, H Igarashi, N Ishiyama, M Nakano, M Ozaki, M Ito, N Masubuchi, S Saito, T Aoyagi, I Yamagishi.   

Abstract

The aim of this study was to clarify the change of the gastric mucosa following inoculation with Helicobacter pylori (H. pylori). Two pairs of cynomolgus monkeys received either H. pylori of human origin (group A) or H. pylori of monkey origin (group B) by intragastric inoculation at a dose of 10(9) CFU. After inoculation, endoscopical observation and biopsies were done every 7 days for one month. The bacteria in the biopsy samples were cultured quantitatively. The content of intracellular PAS-AB positive substance was quantitatively analyzed with the image analyzing system. Results were as follows: 1) Before inoculation, the gastric mucosa was endoscopically normal and free from H. pylori. 2) The quantity of H. pylori varied from 0 to 10(3) CFU/0.1 g tissue in group A and from 10 to 10(6) CFU/0.1 g tissue in group B. 3) Severe erosion was seen in group B, while mild mucosal erythema and erosion were observed in group A. 4) There was a correlation between the quantity of H. pylori and histological activity (Rauws' gastritis score). 5) The PAS-AB positive substance in H. pylori-positive mucosa was less than that in H. pylori-negative mucosa. In conclusion, gastric mucosal changes of varying degrees were brought about after inoculation of H. pylori depending on the quantity of bacilli in the gastric tissue.

Entities:  

Mesh:

Year:  1993        PMID: 8280957     DOI: 10.1016/s0934-8840(11)80940-0

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  1 in total

1.  Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease.

Authors:  A Dubois; D E Berg; E T Incecik; N Fiala; L M Heman-Ackah; G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.